{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:33:42Z","timestamp":1773290022390,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.atherosclerosis.2004.12.022","type":"journal-article","created":{"date-parts":[[2005,4,26]],"date-time":"2005-04-26T11:21:48Z","timestamp":1114514508000},"page":"305-309","source":"Crossref","is-referenced-by-count":84,"title":["Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan"],"prefix":"10.1016","volume":"180","author":[{"given":"Yi-Chun","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Hsien","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Gowth","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaur-Jong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib1","series-title":"\u201cVascular disease of the nervous system: ischemic cerebrovascular disease\u201d in neurology in clinical practice","author":"Biller","year":"2004"},{"issue":"6423","key":"10.1016\/j.atherosclerosis.2004.12.022_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis","volume":"347","author":"Kiechl","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0952-7915(99)80003-X","article-title":"The toll-receptor family and control of innate immunity","volume":"11","author":"Kopp","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0021-9150(99)00346-9","article-title":"Chemokines and atherosclerosis","volume":"147","author":"Reape","year":"1999","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2004.12.022_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2004.01.024","article-title":"Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-alpha stimulated human umbilical vein endothelial cells","volume":"174","author":"Yang","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00168-2","article-title":"Evidence for infectious agents in cardiovascular disease and atherosclerosis","volume":"2","author":"Leinonen","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib9","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1001\/jama.288.21.2724","article-title":"Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease","volume":"288","author":"Kalayoglu","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib10","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/01.CIR.0000032146.75113.EE","article-title":"In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions","volume":"106","author":"Vink","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.pharmtox.43.100901.135729","article-title":"Innate immune responses to microbial poisons: discovery and function of the toll-like receptors","volume":"43","author":"Beutler","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib12","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1074\/jbc.274.16.10689","article-title":"Toll-like receptor 4 mediates lipopolysaccharide-induced signal transduction","volume":"274","author":"Chow","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib13","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates toll-like receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","article-title":"Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor 4 complex","volume":"164","author":"Ohashi","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib15","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1161\/01.ATV.0000101191.92392.1D","article-title":"Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events","volume":"23","author":"Ameziane","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib16","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1161\/01.CIR.0000068311.40161.28","article-title":"Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events","volume":"107","author":"Boekholdt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib17","first-page":"853","article-title":"Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia","volume":"251","author":"Reismann","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutation are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nature Genet"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1096\/fj.03-1263fje","article-title":"Toll-like receptor 4 functions intracellulary in human coronary artery endothelial cells: roles of LBP and SCD 14","volume":"18","author":"Dunzendorfer","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nature Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib22","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4","volume":"167","author":"Smiley","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/hh1501.094184","article-title":"Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44\/p42 mitogen-activated protein kinase activation","volume":"89","author":"Sasu","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2362.2004.01338.x","article-title":"Role of toll-like receptor 4 in the initiation and progression of atherosclerotic disease","volume":"34","author":"Pasterkamp","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib26","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor 4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9150(03)00286-7","article-title":"TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis","volume":"170","author":"Yang","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.12.022_bib28","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJM200212123472416","article-title":"Toll-like receptor 4 polymorphism and atherosclerosis","volume":"347","author":"Beutler","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004006318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004006318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T12:22:08Z","timestamp":1550233328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004006318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0021915004006318"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.12.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}